Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.010 Å; disorder in main residue; R factor = 0.062; wR factor = 0.162; data-to-parameter ratio = 13.2.
Data collection
Bruker SMART CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 1998) T min = 0.682, T max = 0.719 5285 measured reflections 3498 independent reflections 1810 reflections with I > 2(I) R int = 0.029 Refinement R[F 2 > 2(F 2 )] = 0.062 wR(F 2 ) = 0.162 S = 1.06 3498 reflections 265 parameters H-atom parameters constrained Á max = 0.38 e Å À3 Á min = À0.43 e Å À3 Table 1 Hydrogen-bond geometry (Å , ). (ii) Àx þ 1; Ày þ 1; Àz þ 2; (iii) Àx þ 1; Ày þ 1; Àz þ 1.
Data collection: SMART (Bruker, 1998); cell refinement: SAINT (Bruker, 1998); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL. 
3-(4-Bromophenyl

Comment
The pyrimidines and their derivatives as a class of extremely important heterocyclic compounds are used in a wide array of synthetic and industrial applications. Not only they are an integral part of the genetic materials, viz. DNA and RNA as nucleotides and nucleosides but also play critical roles especially in pharmaceutical fields (Johar et al., 2005; Janeba et al., 2005) . Some pyrimidine derivatives can give stable and good quality nanomaterials having many important electrical and optical properties (Soloducho et al., 2003; Mathews & Asokan, 2007) , and also used as functional materials (Lagoja, 2005; Michael, 2005; Erian, 1993) . We report herein the crystal structure of the title compound.
In the molecule of the title compound (Fig 1) , the bond lengths (Allen et al., 1987) and angles are within normal ranges. Rings A (N1/N2/C1-C4), B (C8-C13) and C (C15-C20) are, of course, planar, and they are oriented at dihedral angles of A/B = 80.87 (3)°, A/C = 15.99 (3)° and B/C = 88.37 (3)°.
In the crystal structure, intermolecular N-H···O and O-H···N hydrogen bonds (Table 1 ) link the molecules, in which they may be effective in the stabilization of the structure. The π-π contact between the pyrimidine and the phenyl rings, Cg1-Cg2 [where Cg1 and Cg2 are centroids of the rings A (N1/N2/C1-C4) and C (C15-C20), respectively] may further stabilize the structure, with centroid-centroid distance of 3.776 (3) Å.
Experimental
The title compound was prepared by the reaction of 4-bromophenylidene-Meldrum's acid (1 mmol) with 6-hydroxypyrimidin-4(3H)-one (1 mmol) and (S)-1-phenylethanamine (1 mmol) at 373 K in glacial acetic acid under microwave irradiation (maximum power 250 W, initial power 100 W) for 18 min (yield; 85%, m.p. 551-553 K). Crystals suitable for X-ray analysis were obtained from an ethanol solution by slow evaporation.
Refinement
Atoms C21, H21A, H21B, H21C and H14 were disordered over two positions. During the refinement process the disordered atoms were refined with occupancies of 0.522 (13) and 0.478 (13). H atoms were positioned geometrically, with O-H = 0.82 Å (for OH), N-H = 0.86 Å (for NH) and C-H = 0.93, 0.98, 0.97 and 0.96 Å for aromatic, methine, methylene and methyl H, respectively, and constrained to ride on their parent atoms, with U iso (H) = xU eq (C,N,O), where x = 1.5 for methyl and OH H and x = 1.2 for all other H atoms. Fig. 1 . The molecular structure of the title molecule, with the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. (5) C21 0.071 (9) 0.059 (7) 0.088 (10) 0.001 (6) 0.007 (7) 0.042 (7) C21' 0.094 (13) 0.066 (9) 0.104 (13) 0.014 (9) −0.007 (10) 0.031 (9) Geometric parameters (Å, °) (7) C15-C20 1.375 (9) N3-H3 0.8600 C16-C17 1.387 (10) C1-C2 1.428 (7) C16-H16 0.9300 C2-C3 1.381 (6) C17-C18 1.358 (11) C2-C7 1.495 (7) C17-H17 0.9300 C4-H4 0.9300 C18-C19 1.357 (11) C5-C6 1.500 (7) C18-H18 0.9300 C6-C7 1.534 (6) C19-C20 1.394 (11) C6-H6A 0.9700 C19-H19 0.9300 C6-H6B 0.9700 C20-H20 0.9300 C7-C8 1.520 (7) C21-H14' 0.8878 C7-H7 0.9800 C21-H21A 0.9600 C8-C9 1.360 (7) C21-H21B 0.9600 C8-C13 1.372 (8) C21-H21C 0.9600 C9-C10 1.382 (8) C21'-H21D 0.9600 C9-H9 0.9300 C21'-H21E 0.9600 C10-C11 1.366 (9) C21'-H21F 0.9600 C3-O2-H2 109.5 C11-C12-C13 120.6 (6) C4-N1-C1 123.0 (4) C11-C12-H12 119.7 C4-N1-H1 118.5 C13-C12-H12 119.7 C1-N1-H1 118.5 C8-C13-C12 121. supplementary materials sup-8 Fig. 1 
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